NCT03934203View on ClinicalTrials.gov

This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

September 6, 2019

Study Completion Date

September 6, 2019

Conditions
Healthy
Interventions
DRUG

BI 409306

Film-coated tablet

DRUG

Moxifloxacin

Film-coated tablet

DRUG

Placebo matching to BI 409306

Film-coated tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03934203 - This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study) | Biotech Hunter | Biotech Hunter